key: cord-0689656-u5d9m3ig
authors: Escalera, Alba; Gonzalez-Reiche, Ana S.; Aslam, Sadaf; Mena, Ignacio; Laporte, Manon; Pearl, Rebecca L.; Fossati, Andrea; Rathnasinghe, Raveen; Alshammary, Hala; van de Guchte, Adriana; Farrugia, Keith; Qin, Yiren; Bouhaddou, Mehdi; Kehrer, Thomas; Zuliani-Alvarez, Lorena; Meekins, David A.; Balaraman, Velmurugan; McDowell, Chester; Richt, Jürgen A.; Bajic, Goran; Sordillo, Emilia Mia; Dejosez, Marion; Zwaka, Thomas P.; Krogan, Nevan; Simon, Viviana; Albrecht, Randy A.; van Bakel, Harm; Garcia-Sastre, Adolfo; Aydillo, Teresa
title: Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
date: 2022-01-21
journal: Cell Host Microbe
DOI: 10.1016/j.chom.2022.01.006
sha: 69c26cefddc74b170a88a9cee6c3b1a125e28ce7
doc_id: 689656
cord_uid: u5d9m3ig

SARS-CoV-2 lineages have diverged into highly prevalent variants termed Variants of Concern (VOCs). Here, we characterized emerging SARS-CoV-2 spike polymorphisms in vitro and in vivo to understand their impact on transmissibility, virus pathogenicity and fitness. We demonstrate that the substitution S:655Y, represented in the Gamma and Omicron VOCs, enhances viral replication and spike protein cleavage. The S:655Y substitution was transmitted more efficiently than its ancestor S:655H in the hamster infection model and was able to outcompete S:655H in the hamster model and in a human primary airway system. Finally, we analyzed a set of emerging SARS-CoV-2 variants to investigate how different sets of mutations may impact spike processing. All VOCs tested exhibited increased spike cleavage and fusogenic capacity. Taken together, our study demonstrates that the spike mutations present in VOCs that become epidemiologically prevalent in humans, are linked to an increase in spike processing and virus transmission.

SARS-CoV-2 has been spreading worldwide causing millions of infections and deaths since its emergence 58 in Wuhan, China, in late 2019. Apart from humans, ferrets, cats, dogs, Syrian golden hamsters, and 59 nonhuman primates are also susceptible to SARS-CoV-2 infection and transmission (Fenollar et al., 2021;  60 Shi et al., 2020 ). In addition, cases of viral spread in mink farms and mink-to-human cross-species The S1/S e an internal fusi n interna have emerged le ave emerg ts of Concern (VO f Conc different functio rent fun re research is ne esearch is potential impact ential imp evious i s infection a nfectio was the the spike p pik present in most present in mo viral replication al replica al., 2021) , 202 tly e 117 sets of mutations may impact spike processing. We demonstrated that novel circulating VOCs that became Figure 1C) . We then 141 selected small and large viral plaques in the Vero-E6 cell-based plaque assays from infected mink lung 142 specimens and performed next generation sequencing of the genome from the plaque-isolated viruses.

As compared to the Wuhan-1 and WA1 reference sequences, all mink-derived viral isolates encoded the 144 H655Y amino acid substitution within the spike (S) (Supplementary Figure 1D) . Additionally, the three viral

isolates with the small plaque phenotype encoded the T259K amino acid substitution while the three viral 146 isolates with the large plaque phenotype encoded the R682W amino acid substitution. It is known that 

To understand the magnitude and the spread of the 655Y polymorphism over time, we investigated the 157 frequency of S:655Y in sequences sampled worldwide since the initial outbreak to the end of the first 158 wave of SARS-CoV-2 ( Figure 1A ). For this, 7,059 sequences sampled from GISAID up to September 2020 159 were used. Human variants harboring the 655Y mutation were spread throughout the phylogenetic tree patients. This is consistent with in vitro adaptative mutations previously described (Lamers et al., 2021) . 

These results support our conclusion that the 655Y polymorphism conferred a viral advantage. To isolates. Consistently, quantification of full-length and cleaved spike protein showed that around 80% of 191 the NY7 (S:655Y) spike was in its S2 cleaved form ( Figure 1C) 

Western blot ( Figure 1D ). As expected, NY7 (S:655Y) showed an increase cleavage efficiency with 70% of 198 cleaved spike protein ( Figure 1E) Figure 3A) . However, differences were found by Western blot 221 and only the isolates bearing 655Y showed enhanced spike cleavage in both VeroE6 and Vero-TMPRSS2 222 ( Figure 2C ). More than 90% of the total spike protein from these 655Y variants corresponded to the S2 223 cleaved form of the spike. In contrast, NY6 and WA1 controls showed poor cleavage efficiency ( Figure 2D 224 and E). Finally, we performed infections with a representative panel of viruses containing the 655Y (NY7,

NY13, WA1-655Y, NY6, WA1) in human pneumocytes-like cells to assess viral growth and spike protein 226 processing. Consistent with our previous findings, WA1-655Y demonstrated higher replication efficiency 227 in our human airway epithelial system compared to WA1 wild type ( Figure 2F , Supplementary Table 4) .

Moreover, all isolates encoding the 655Y spike mutation exhibited enhanced spike cleavage as shown by

Western Blot ( Figure 2G and H). This demonstrates that the S:655Y polymorphism plays a crucial role in 230 SARS-CoV-2 spike protein processing and cell entry in human pneumocyte-like cells.

Syncytia formation has been described as one of the hallmarks of SARS- Figure 4A) . Figure 3C shows GFP signal from each 248 spike variant normalized to the DAPI positive cells and spike expression levels. Differences 249 in fusogenicity were then calculated relative to WA1 wild type spike. We observed that spike proteins 250 harboring the 655Y were more fusogenic and induce higher levels of syncytia than WA1 and NY6 spikes.

As expected, the WA1 spike with a deleted furin cleavage site resulted in significantly less fusion,

indicating that an intact furin cleavage site is required for syncytia formation. 

Next, we performed viral competition experiments ( Figure 4H) Figure 5D ). In contrast,

Kappa and Delta variants harbor polymorphism P681R ( Figure 5D ). Finally, the frequency of A701V 329 mutation was higher in Beta and Iota variants which emerged in October and November 2020, 330 respectively ( Figure 5E ).

Next, we analyzed the in vitro phenotype of some of the most prevalent SARS-CoV-2 VOCs. Multiple 333 protein sequence alignment of the VOCs used are shown in Figure 6A . In contrast to the NY isolates 334 previously analyzed, VOCs showed a considerable number of unique changes across the whole spike 335 protein. However, small differences in replication kinetics and plaque phenotypes were observed in Vero-

TMPRSS2 cells ( Figure 6B and Supplementary Figure 3B ). Conversely, bigger differences were observed 337 when replication efficiency was determined in VeroE6 cells at 24 hours post-infection (p.i.) ( Figure 6B ).

Additionally, viral supernatants were titrated on both VeroE6 and Vero-TMRPSS2 cells (Supplementary 339 Figure 3B ). Substantial differences in plaque phenotypes were observed, especially for the Kappa 

Similarly, Kappa and Delta variants showed the greater levels of cleaved spike in Vero-TMPRSS2 cells 355 compared to the WA1 ( Figure 6D ). Next, we evaluated the replication kinetics and spike protein processing 

Nonetheless, when we assessed the extent of the spike protein processing, all VOCs showed an enhanced 362 spike cleavage compared to WA1 isolates ( Figure 6F and G).

The canonical cleavage at the S1/S2 site occurs at the last arginine (R) of the multibasic PRRAR motif and 365 is performed by furin proteases at this specific residue. Thus, we next quantified the abundance of furin- 

As shown in Figure 7B , a loss of fusogenic activity was observed when compared to the intact Kappa VOC.

These results were consistent with our previous findings showing that the fusogenic ability of the WA1 is present in all the VOCs studied here. We observed that the D614G mutation alone (WA1 614G ) increased 403 fusogenicity compared to the WA1 spike. This is consistent with the advantage in spike processing 404 observed in human lung cells in vitro ( Figure 1D ). Since it is clear now that D614G also contributes to some 405 extent to spike processing, the impact of single point mutations like H655Y could be masked when 614G 406 was present. Therefore, this indicates all these mutations individually contribute to enhance fusion and 407 their combination might even increase spike processing and cell fusion, especially in conditions with 408 limiting host protease activity, which may occur in vivo.

Altogether, our results are consistent with the notion that current highly transmissible circulating VOCs 

Here, we demonstrate that viruses containing the H655Y polymorphism confer a growth advantage in 

Intense worldwide surveillance has established that SARS-CoV-2 variants are constantly emerging. In Delta variants -first emerged in India-allowed this enhanced S cleavage. Interestingly, for these three 472 variants, optimal cleavage appeared to be dependent on TMPRSS2 protease activity present in the human 473 epithelial airway ( Figure 6C and F). To note, the Omicron variant not only contains the 655Y but also 681H 474 and 614G. Additionally, the N679K polymorphism is also present. Therefore, this combination of 475 mutations points to an enhancement on transmissibility.

To confirm the cleavage at the putative furin cleavage site, we determined the relative abundance of the 478 furin cleaved peptide produced after the 685-terminal arginine. We observed higher amount of cleavage 

In summary, our study demonstrates that the 655Y spike polymorphism, present in the Gamma and now NTD is colore op (disordered a p (disorde protomer is show otomer gion of interest a of intere are highlighted in highlighted ting the tempora the temp ng the S1/S2 regio e S1/S2 r nalysis was perfo ysis was p ons between S:6 ns between quency per cl ncy per c ad 

All cell lines were grown at 37°C in 5% CO2.

Plasmids: Spike expression plasmids were constructed by extracting viral RNA from the corresponding Hours p.i. 

Alpha Beta Gamma Kappa Delta

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV

Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect 1071 In Vivo in a Mouse Model in a Neutralization-Dependent Manner. mBio

Shedding of Viable SARS-CoV-2 after 1075 Immunosuppressive Therapy for Cancer

Immunological imprinting 1079 of the antibody response in COVID-19 patients

Mutational spectra of 1082 SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid 1086 mutational escape seen with individual antibodies

Specific mutations in SARS-CoV2 RNA dependent RNA polymerase and helicase alter 1090 protein structure, dynamics and thus function: Effect on viral RNA

TMPRSS2 and furin are both essential for 1094 proteolytic activation of SARS-CoV-2 in human airway cells

Transmission of SARS-CoV-2 in domestic 1098 cats imposes a narrow bottleneck

Syncytia formation by SARS-CoV-2-1101 infected cells

A neutralizing human antibody binds to the N-terminal domain of the Spike 1104 protein of SARS-CoV-2

The 1106 spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in 1107 CoV of the same clade

Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of 1110

Infection and vaccine-induced neutralizing antibody 1113 responses to the SARS-CoV-2 B.1.617.1 variant

Mink, SARS-CoV-2, and the Human-Animal Interface

Human iPS cell-derived alveolar epithelium repopulates 1119 lung extracellular matrix

Introductions and early spread of SARS-1122

CoV-2 in the New York City area

Nextstrain: real-time tracking of pathogen evolution

SARS-CoV-2 1128 Transmission between Mink (Neovison vison) and Humans

SARS-CoV-2 variants, spike 1132 mutations and immune escape

A Multibasic Cleavage Site in the 1134

Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Structural and functional properties 1137 of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Derivation of self-renewing lung alveolar epithelial type II 1141 cells from human pluripotent stem cells

Furin Cleavage Site Is Key to SARS-CoV-2 1144

A new cell-based assay to evaluate myogenesis in mouse 1147 myoblast C2C12 cells

MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based 1150 proteomics

Consortium , Consor e escape. Nat Re cape

Tracking Changes in SARS-CoV-2 Spike: 1153 Evidence that D614G Increases Infectivity of the COVID-19 Virus

Human airway cells 1157 prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the 1161 ACE2 receptor

Minimap2: pairwise alignment for nucleotide sequences

Syncytia formation during SARS-CoV-2 lung 1165 infection: a disastrous unity to eliminate lymphocytes

The N501Y spike substitution enhances SARS-CoV-2 transmission

Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory 1172 Syndrome Coronavirus 2

Skyline: an open source document editor 1175 for creating and analyzing targeted proteomics experiments

Efficient 1178 activation of the severe acute respiratory syndrome coronavirus spike protein by the 1179 transmembrane protease TMPRSS2

SARS-CoV-2 B.1.617.2 Delta variant emergence, replication 1182 and sensitivity to neutralising antibodies. bioRxiv

SARS-CoV-2 B.1.617.2 Delta variant replication and 1186 immune evasion

The sequence at Spike S1/S2 site enables cleavage by 1188 furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

COBALT: constraint-based alignment tool for 1195 multiple protein sequences

The SARS-CoV-2 variants associated 1198 with infections in India, B.1.617, show enhanced spike cleavage by furin. bioRxiv

Sensitivity of infectious SARS-CoV

B.1.1.7 and B.1.351 variants to neutralizing antibodies

Reduced sensitivity of SARS-CoV-2 variant 1206 Delta to antibody neutralization

Spike mutation D614G alters SARS-CoV-2 fitness

Multiplex PCR method for MinION 1212 and Illumina sequencing of Zika and other virus genomes directly from clinical samples

The N501Y mutation in SARS-CoV-2 spike 1216 leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination 1217 human sera

Spatiotemporal dissemination pattern of SARS-CoV-2 B1.1.28-1220 derived lineages introduced into Uruguay across its southeastern border with Brazil. medRxiv

Discovery of SARS-CoV-1224 2 antiviral drugs through large-scale compound repurposing

Defining the Syrian hamster as a highly susceptible 1228 preclinical model for SARS-CoV-2 infection

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-1232 coronavirus 2

Pathogenesis and transmission of SARS-1235

CoV-2 in golden hamsters

Inhibition of Beta interferon induction by severe acute respiratory syndrome 1238 coronavirus suggests a two-step model for activation of interferon regulatory factor 3

Deep Mutational Scanning of SARS-CoV-1242 G., Zhan Zh 4G alters SA alters

The N50

The N and is neutralize and is neutr .19.21249592. 2124 ntes, I

T s through larg through 020 0-2577 2577--1. 1 de-White, K Wh turda 28

Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases 1246 beyond Furin

Memory B cell repertoire for recognition of evolving 1249 SARS-CoV-2 spike

Plitidepsin has potent preclinical efficacy 1252 against SARS-CoV-2 by targeting the host protein eEF1A

Elegant Graphics for Data Analysis

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike 1258 protein

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with 1261 ACE2 and neutralizing antibodies

Phylogenetic analysis: phylogenetic analysis was performed using the same dataset from above to build a 

Statistical analysis: statistical analysis was performed using GraphPad Prism. Two-way ANOVA with Holm-

Šídák posttest and one-way ANOVA with the Tukey's correction was used for multiple comparisons. Two-1061 tailed t test was performed to compare mean differences in cell fusion between each VOC S and 1062 corresponding reverse mutant. Mann-Whitney t test was performed to compare differences in viral titers 1063 in nasal washes, nasal turbinates and lungs of direct infected and contact hamsters. Statistical significance 1064 was considered when p ≤ 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant).

Highlights:The S:655Y mutation in SARS-CoV-2 enhances spike protein cleavage and fusogenicity The S:655Y mutation increases transmissibility in vivo S:655Y was able to outcompete ancestral S:655H in vivo SARS-CoV-2 VOCs evolve to acquire an increased spike cleavage and fusogenic ability eTOC:Escalera et al., show that spike mutation H655Y which is present in SARS-CoV-2 variants Gamma and Omicron, enhances spike protein cleavage, cell-cell fusion, and transmission in the hamster model. Additionally, SARS-CoV-2 variants of concern are shown to have independently acquired mutations associated with a gain in spike cleavage and syncytia formation.